Litigation

Recent Posts

Drug Pump Claims Preempted Expressly, Implicitly, 9th Circuit Panel Majority Says
Posted on 17 Apr 2012 by Tom Moylan

SAN FRANCISCO - (Mealey's) In a 2-1 ruling, a panel of the Ninth Circuit U.S. Court of Appeals said April 16 that claims that a Medtronic drug pump and spine catheter caused a plaintiff to become a paraplegic are preempted explicitly and implicitly... Read More

Tags: MDA , preemption , paraplegic , Richard Stengel , drug pump , intrathecal catheter , Riegel v. Medtronic , Medical Device Amendments , FDA , Food Drug and Cosmetic Act , Medtronic , medical devices , FDCA , Litigation , Richard Stengel v. Medtronic Incorporated , Buckman v. Plaintiffs' Legal Committee , Ninth Circuit , federal medical device law , U.S. Supreme Court , SynchroMed EL drug pump , spine catheter

U.S. High Court Allows Solicitor General To Argue For Drug Design Defect Preemption
Posted on 4 Mar 2013 by Tom Moylan

WASHINGTON, D.C. - (Mealey's) The U.S. solicitor general will be allowed to argue March 19 that design defect claims involving generic drugs are preempted by federal law, the U.S. Supreme Court decided March 4 in granting the federal government's... Read More

Tags: Cipollone v. Liggett Group , nonsteroidal anti-inflammatory drug , Clinoril , preemption , NSAID , TEN , SJS , design defect , toxic epidermal necrolysis , Stevens-Johnson syndrome , Riegel v. Medtronic , Mutual Pharmaceutical Company , U.S. solicitor general , First Circuit , Inc. v. Karen L. Bartlett , Litigation , Inc. v. Mensing , Pliva , generic drugs , U.S. Supreme Court , sulindac , Karen L. Bartlett